GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Steep Hill Inc (XCNQ:STPH) » Definitions » Valuation Rank

Steep Hill (XCNQ:STPH) Valuation Rank


View and export this data going back to 2020. Start your Free Trial

What is Steep Hill Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Steep Hill Valuation Rank Related Terms

Thank you for viewing the detailed overview of Steep Hill's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Steep Hill (XCNQ:STPH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Steep Hill Inc (XCNQ:STPH) » Definitions » Valuation Rank
Comparable Companies
XCNQ:HMPS TSXV:KMC.H XCNQ:XBRA XCNQ:MJMJ XCNQ:REZN TSXV:NAV XCNQ:MLCL XCNQ:MGW TSXV:NU XCNQ:SILO ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
120 Adelaide Street West, Suite 2500, Toronto, ON, CAN, M5H 1T1
Website
https://www.steephill.com
Steep Hill Inc is a science and technology health and wellness company focused on the hemp markets inclusive of plant-based, psychedelic pharmaceutical and non-psychedelic nutraceutical, and hemp cannabinoids (CBD) verticals. Currently the company, through its subsidiaries holds three industrial hemp licences for the purposes of supplying the global market with medicinal and wellness cannabidiol and other cannabinoid-based products.